Cellular longevity research, GLP-1 therapeutics, neuroscience, and precision medicine.
Groundbreaking clinical trials in cellular reprogramming and epigenetic clock reversal are paving the way for therapies that target biological aging at the molecular level.
Clinical trials reveal neuroprotective, anti-inflammatory, and systemic cardiovascular enhancements from multi-agonist metabolic therapeutics.
Sub-millimeter tactile robotic arms paired with real-time AI computer vision are executing complex microsurgeries with zero tremor and minimal patient trauma.